Opthea Limited (ASX:OPT) Completes Final Patient Visit in Phase 3 COAST Trial
Opthea (ASX:OPT) completes final patient visit in COAST Phase 3 trial, anticipating topline results in early Q2 CY25.
Opthea (ASX:OPT) completes final patient visit in COAST Phase 3 trial, anticipating topline results in early Q2 CY25.
Macmahon Holdings Limited (ASX:MAH) reports a 21.98% revenue increase for six months ended December 2024, with profits down by 17.83% and declares an interim dividend.
Biome Australia (ASX:BIO) reports its first net profit in H1 FY25 and launches Vision 27 strategic plan with $75-$85m revenue guidance.
Augustus Minerals (ASX:AUG) uses AI to identify 18 new gold targets at its Music Well project, enhancing exploration efforts.
Inca Minerals Limited (ASX:ICG) announces a revised timetable for its takeover offer of Stunalara Metals Limited.
Biome Australia Limited (ASX:BIO) reports a 47% revenue increase and a net profit of $433k for the half-year ended 31 December 2024.
ARB Corporation (ASX:ARB) reports a 5.9% revenue increase in H1 FY2025 and declares a 34.0c interim dividend.
Big River Industries Limited (ASX:BRI) reports 1H FY25 results with a revenue of $211.5m and declares an interim dividend of 2.0 cents per share.
Seek Limited (ASX:SEK) reports strong H1 FY2025 performance with increased yield and a 26% rise in interim dividends.
BHP Group (ASX:BHP) reports an 8% revenue decline and a 376% profit increase for the half-year, declaring a US$2.5 billion interim dividend.